HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hisakazu Nishimori Selected Research
Hisakazu Nishimori Research Topics
Disease
9
Neoplasms (Cancer)
02/2024 - 05/2005
8
Bronchiolitis Obliterans Syndrome
04/2024 - 01/2012
4
Infections
02/2024 - 06/2021
3
Fatigue
04/2024 - 01/2021
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2023 - 04/2009
3
Graft vs Host Disease (Graft-Versus-Host Disease)
04/2022 - 01/2013
3
Pneumonia (Pneumonitis)
01/2022 - 01/2013
3
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2021 - 10/2020
3
Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 05/2009
2
Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
04/2024 - 01/2021
2
B-Cell Lymphoma (Lymphoma, B Cell)
02/2024 - 01/2023
2
Headache (Headaches)
02/2023 - 01/2021
2
Cytopenia
01/2023 - 09/2020
2
Inflammation (Inflammations)
01/2023 - 01/2013
2
Injection Site Reaction
09/2022 - 01/2021
2
Chronic Disease (Chronic Diseases)
09/2022 - 01/2021
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2022 - 01/2017
2
Hemolysis
09/2022 - 01/2021
2
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
07/2022 - 01/2019
2
Wilms Tumor (Wilm's Tumor)
04/2022 - 01/2017
2
Acute Promyelocytic Leukemia
04/2021 - 10/2016
2
Carcinoma (Carcinomatosis)
06/2019 - 05/2005
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 01/2014
1
COVID-19
02/2024
1
Residual Neoplasm
02/2023
1
Photophobia (Light Sensitivity)
02/2023
1
Retinoblastoma (Glioblastoma, Retinal)
02/2023
1
Neutropenia
01/2023
1
Cytokine Release Syndrome
01/2023
1
Hypoxia (Hypoxemia)
12/2022
1
Nasopharyngitis
09/2022
1
Sinusitis
07/2022
1
Rubella (German Measles)
06/2022
1
Mumps
06/2022
1
Measles
06/2022
1
Chickenpox
06/2022
1
Herpes Zoster
06/2022
1
Chorea (Rheumatic Chorea)
10/2021
1
Lymphoma (Lymphomas)
09/2021
1
Sepsis (Septicemia)
06/2021
1
Endometrial Neoplasms (Endometrial Cancer)
04/2021
1
Diarrhea
01/2021
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1
Philadelphia Chromosome
01/2021
1
Circulating Neoplastic Cells
10/2020
Drug/Important Bio-Agent (IBA)
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2022 - 04/2009
3
pegcetacoplan
IBA
04/2024 - 01/2021
3
Hemoglobins (Hemoglobin)
IBA
04/2024 - 06/2012
3
eculizumab
FDA Link
04/2024 - 01/2021
3
Rituximab (Mabthera)
FDA Link
12/2020 - 04/2009
2
Chimeric Antigen Receptors
IBA
02/2024 - 01/2023
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2023 - 01/2014
2
Cytokines
IBA
01/2023 - 01/2013
2
Azacitidine (5 Azacytidine)
FDA Link
09/2022 - 01/2017
2
fludarabine
IBA
09/2022 - 01/2021
2
Cytarabine (Cytosar-U)
FDA Link
Generic
09/2022 - 05/2009
2
Acids
IBA
03/2021 - 10/2020
2
Antigens
IBA
06/2019 - 01/2017
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2019 - 05/2009
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2017 - 04/2009
2
Prednisone (Sone)
FDA Link
Generic
12/2017 - 04/2009
2
Etoposide (VP 16)
FDA Link
Generic
12/2017 - 05/2009
2
Vincristine (Oncovin)
FDA Link
Generic
12/2017 - 04/2009
2
tamibarotene
IBA
10/2016 - 01/2012
2
Steroids
IBA
10/2016 - 01/2014
2
Cisplatin (Platino)
FDA Link
Generic
10/2010 - 05/2005
2
Docetaxel (Taxotere)
FDA Link
10/2010 - 05/2005
1
Complement C3 (C3 Complement)
IBA
04/2024
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
04/2024
1
cilgavimab
IBA
02/2024
1
Antiviral Agents (Antivirals)
IBA
02/2024
1
tixagevimab
IBA
02/2024
1
carboxyl radical (COO-)
IBA
12/2023
1
tisagenlecleucel
IBA
01/2023
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
12/2022
1
plerixafor
FDA Link
12/2022
1
venetoclax
IBA
09/2022
1
Messenger RNA (mRNA)
IBA
04/2022
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
09/2021
1
Arsenic Trioxide (Trisenox)
FDA Link
04/2021
1
Complement System Proteins (Complement)
IBA
01/2021
1
Alkylating Agents
IBA
01/2021
1
Peptides (Polypeptides)
IBA
01/2021
1
protoporphyrin IX
IBA
10/2020
1
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
10/2020
1
Biomarkers (Surrogate Marker)
IBA
10/2020
1
Immunoglobulin Isotypes
IBA
09/2020
Therapy/Procedure
17
Therapeutics
02/2024 - 04/2009
11
Drug Therapy (Chemotherapy)
02/2024 - 05/2005
11
Hematopoietic Stem Cell Transplantation
12/2022 - 01/2013
7
Cell Transplantation
04/2024 - 01/2014
5
Transplantation
09/2022 - 05/2009
2
Photochemotherapy (Photodynamic Therapy)
03/2021 - 10/2020
2
Salvage Therapy
01/2021 - 01/2017
1
Radiotherapy
02/2023
1
Chemoradiotherapy
02/2023
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2022
1
Stem Cell Transplantation
01/2022
1
Photopheresis
10/2020